CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $2.38 million for the 12-month period ending 2020-12-26, per its 10-K filed 2023-02-22.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2023-02-22
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2020-12-26 was $2.38M, a 77.59% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2020-09-26 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2020-06-27 was -$2.38M, a 227.22% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2020-03-28 was $2.38M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2020 was $2.38M, a 27.22% increase from fiscal 2019.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2019 was $1.87M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2017 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2008 was $2.44M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 6 month as first filed | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month as first filed | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month |
|---|---|---|---|---|---|---|
| 2020-12-26 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.38M derived: sum of 2 quarters · filed 2023-02-22 | $0.00 derived: sum of 3 quarters · filed 2023-02-22 | $2.38M 10-K · filed 2023-02-22 | ||
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$2.38M derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $10.62M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-06-27 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $10.62M derived: sum of 3 quarters · filed 2022-02-16 | $10.62M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-03-28 | $2.38M 10-Q · filed 2021-11-03 | $12.99M derived: sum of 2 quarters · filed 2022-02-16 | $12.99M derived: sum of 3 quarters · filed 2022-02-16 | $14.86M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2019-12-28 | $10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $10.62M derived: sum of 2 quarters · filed 2022-02-16 | $12.48M derived: sum of 3 quarters · filed 2022-02-16 | $1.87M 10-K · filed 2022-02-16 | ||
| 2019-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.87M derived: sum of 2 quarters · filed 2020-10-29 | -$8.74M 10-Q · filed 2020-10-29 | $8.74M 10-Q · filed 2019-11-06 | ||
| 2019-06-29 | $1.87M 10-Q · filed 2020-10-29 | -$8.74M 10-Q · filed 2020-08-05 | $8.74M 10-Q · filed 2019-07-31 | |||
| 2018-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-31 | |||||
| 2017-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 10-K · filed 2018-02-13 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | |||||
| 2017-04-01 | $0.00 10-Q · filed 2017-05-10 | |||||
| 2016-12-31 | $12.36M 10-K · filed 2019-02-13 | |||||
| 2016-09-24 | $12.36M 10-Q · filed 2017-11-09 | |||||
| 2016-03-26 | $0.00 10-Q · filed 2017-05-10 | |||||
| 2008-12-27 | $2.44M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |